Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome

Table 3 The rating scales and urodynamic data of HIC and NHIC

Characteristic	NHIC	HIC	p
n	44	26
NLR	2.14 ± 0.71	3.34 ± 1.66	0.001
Medical history, months	57.52 ± 60.71	76.46 ± 119.36	0.39
Daytime voids, ml	20.19 ± 10.71	17.5 ± 9.41	0.308
Nighttime voids, ml	6.51 ± 3.7	7.46 ± 3.61	0.315
Total voids, ml	26.7 ± 11.82	23.04 ± 12.77	0.231
Average voided volumes, ml	160.06 ± 106.95	140 ± 69.66	0.44
VAS	5.07 ± 2.94	6.17 ± 2.81	0.142
ICPI	11.49 ± 2.81	12.83 ± 3.37	0.085
ICSI	11.86 ± 3.89	12.92 ± 4.94	0.338
PUF Symptom Scale	12.93 ± 3.79	14.29 ± 4.85	0.207
PUF distress Scale	7.07 ± 2.86	7.62 ± 2.76	0.443
PUF	20 ± 5.91	21.92 ± 6.91	0.235
OABSS	7.49 ± 2.41	7.5 ± 3.22	0.987

Data are presented as mean ± SD, n (%), median (IQR). NLR, Neutrophil-to-lymphocyte ratio; VAS, Visual Analogue Scale/Score; ICSI, Interstitial Cystitis Symptom Index; ICPI, Interstitial Cystitis Problem Index; PUF, Pelvic Pain and Urgency/Frequency questionnaire; OABSS, overactive bladder syndrome score

ISSN: 1471-2490